Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 14Carcinoma, Basal Cell 7Bowen's Disease 4Warts 1Uterine Cervical Dysplasia 1Skin Neoplasms 1Skin Diseases 1Neoplasms, Basal Cell 1Keratosis 1Connective Tissue Diseases 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

Cisplatin 55Carboplatin 50pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Cetuximab 18Docetaxel 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 13Sorafenib 12Radiation 11130-nm albumin-bound paclitaxel 11Sunitinib 10Platinum 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × methyl 5-aminolevulinate × Clear all
NCT00535080 2021-02-18

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Galderma R&D

No longer available
Dermatologic

Bowen's Disease, Carcinoma, Carcinoma, Basal Cell, Keratosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡